|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.003 AUD | -25.00% |
|
-33.33% | -92.50% |
| Apr. 16 | Melodiol Global's Revenue Surges 79% in Q1 | MT |
| Apr. 09 | Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic | MT |
Melodiol Global Health Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was AUD 7 million compared to AUD 4.32 million a year ago. Net loss was AUD 28.25 million compared to AUD 7.09 million a year ago.
Basic loss per share from continuing operations was AUD 0.26 compared to AUD 0.112 a year ago. Diluted loss per share from continuing operations was AUD 0.26 compared to AUD 0.112 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -92.50% | 1.32M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
MELODIOL GLOBAL HEALTH LIMITED 
